Franklin Resources
VIR icon

Franklin Resources’s Vir Biotechnology VIR Stock Holding History

Franklin Resources’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-205,994
Closed -$1.18M – 3279
2025
Q3 		$1.18M Sell
205,994
-46,720
-18% -$239K ﹤0.01% 2021
2025
Q2 		$1.27M Buy
252,714
+43,980
+21% +$236K ﹤0.01% 1896
2025
Q1 		$1.35M Buy
+208,734
New +$1.86M ﹤0.01% 1833
2024
Q4 		– Sell
-97,948
Closed -$751K – 3030
2024
Q3 		$751K Sell
97,948
-2,233
-2% -$19.4K ﹤0.01% 2104
2024
Q2 		$892K Sell
100,181
-2,713
-3% -$26K ﹤0.01% 1971
2024
Q1 		$1.04M Buy
102,894
+88,055
+593% +$897K ﹤0.01% 1936
2023
Q4 		$149K Sell
14,839
-935
-6% -$8.54K ﹤0.01% 2409
2023
Q3 		$148K Sell
15,774
-14,507
-48% -$207K ﹤0.01% 2393
2023
Q2 		$743K Buy
30,281
+18,132
+149% +$455K ﹤0.01% 1771
2023
Q1 		$283K Buy
12,149
+2,165
+22% +$55.4K ﹤0.01% 1882
2022
Q4 		$253K Buy
+9,984
New +$245K ﹤0.01% 1920
2022
Q3 		– Sell
-9,230
Closed -$235K – 2411
2022
Q2 		$235K Sell
9,230
-3,200
-26% -$74.7K ﹤0.01% 1966
2022
Q1 		$320K Sell
12,430
-230
-2% -$6.82K ﹤0.01% 1989
2021
Q4 		$530K Buy
+12,660
New +$496K ﹤0.01% 1884

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GP
GSK plc London $602M AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Franklin Resources's VIR Position: Q4 2025 in Review

Franklin Resources sold out of Vir Biotechnology (VIR) in Q4 2025, closing a stake of 205,994 shares — an estimated $1.18M sold.

Franklin Resources first reported a position in VIR in Q4 2021 and held it in 14 quarters. The position peaked at $1.35M in Q1 2025. 218 funds tracked by Wall St. Rank hold VIR as of Q4 2025.

  • Franklin Resources reported no remaining Vir Biotechnology position as of Q4 2025 after selling out during the quarter.
  • Franklin Resources sold 205,994 Vir Biotechnology shares in Q4 2025, an estimated $1.18M.
  • Franklin Resources first reported a position in Vir Biotechnology in Q4 2021 and held it in 14 quarters.
  • Franklin Resources's Vir Biotechnology position peaked at $1.35M in Q1 2025.
  • 218 funds tracked by Wall St. Rank held Vir Biotechnology as of Q4 2025.

Based on Franklin Resources's 13F filing for Q4 2025, filed 11 Feb 2026.